Renegado, Carmelito L.

HRN: 19-27-71  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/13/2025
10/13/2025
IV
4.5
LOADING DOSE
Severe Sepsis Secondary To Cap Mr
Waiting Final Action 
10/13/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/13/2025
10/19/2025
IV
2.25
Q8
Severe Sepsis
Waiting Final Action 
10/13/2025
AZITHROMYCIN 500MG TABLET (TAB)
10/13/2025
10/17/2025
PO
500
Od
Sepsis
Waiting Final Action 
10/14/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/14/2025
10/20/2025
IV
2.25g
Q6
CAP-HR
Waiting Final Action 
10/19/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/19/2025
10/26/2025
IV
830mg
OD
CAP-HR
Waiting Final Action 
10/30/2025
CEFTAZIDIME 1GM (VIAL)
10/30/2025
11/05/2025
IV
1g
Q8h
Capmr
Checking Final Appropriateness 
11/02/2025
CEFTAZIDIME 1GM (VIAL)
11/02/2025
11/08/2025
IVTT
2g
Q8
Cap-MR
Waiting Final Action 
11/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/06/2025
11/13/2025
IV
500mg
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: